The four different groups of patients with PD-L1 positivity or negativity in tumor cells and/or TIIC (i.e. both tumor and TIIC positive, tumor positive/TIIC negative, tumor negative/TIIC positive, both tumor and TIIC negative) did not show any significant difference with regard to DFS, DSS or OS. This evidence concerns the gene CD274 and neoplasm.